Page last updated: 2024-09-02

tanshinone and arginyl-glycyl-aspartic acid

tanshinone has been researched along with arginyl-glycyl-aspartic acid in 2 studies

Compound Research Comparison

Studies
(tanshinone)
Trials
(tanshinone)
Recent Studies (post-2010)
(tanshinone)
Studies
(arginyl-glycyl-aspartic acid)
Trials
(arginyl-glycyl-aspartic acid)
Recent Studies (post-2010) (arginyl-glycyl-aspartic acid)
1,445101,0334,556171,799

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cai, J; Costanza, F; Fan, Z; Ji, G; Li, Q; Song, D; Wang, Y1
Dong, Z; Guo, J; Wang, Y; Xing, X; Yan, J; Zhang, G; Zhang, X1

Other Studies

2 other study(ies) available for tanshinone and arginyl-glycyl-aspartic acid

ArticleYear
Targeted delivery of tanshinone IIA-conjugated mPEG-PLGA-PLL-cRGD nanoparticles to hepatocellular carcinoma.
    Journal of biomedical nanotechnology, 2014, Volume: 10, Issue:11

    Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Diffusion; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Nanocapsules; Oligopeptides; Polyesters; Polyethylene Glycols; Polylysine; Treatment Outcome

2014
Acute myocardial infarction therapy using calycosin and tanshinone co-loaded; mitochondrion-targeted tetrapeptide and cyclic arginyl-glycyl-aspartic acid peptide co-modified lipid-polymer hybrid nano-system: preparation, characterization, and anti myocard
    Drug delivery, 2022, Volume: 29, Issue:1

    Topics: Abietanes; Animals; Isoflavones; Lipids; Mitochondria; Myocardial Infarction; Nanoparticles; Oligopeptides; Peptides, Cyclic; Polymers; Rats

2022